Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02033083 · ClinicalTrials.gov registry record · NA
Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation
A NA study of Second Trimester Abortion, sponsored by Planned Parenthood of Greater New York.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT02033083: Completed NA study of Second Trimester Abortion, sponsored by Planned Parenthood of Greater New York.
NCT02033083 is a NA study of Second Trimester Abortion that has completed, run by Planned Parenthood of Greater New York. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02033083, a NA study of Second Trimester Abortion, has completed, sponsored by Planned Parenthood of Greater New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary objective: To study the difference in dilation and evacuation (D\&E) procedure time following overnight cervical preparation with laminaria or Dilapan-S™. The investigators hypothesize procedure time will be less with Dilapan-S™. Secondary objectives: To compare the use of laminaria and Dilapan-S™ for differences in: (1) initial cervical dilation before D\&E; (2) need for mechanical dilation to accomplish D\&E and ease of dilation if required; (3) number of osmotic dilators placed; (4) ability to complete the D\&E procedure without further cervical preparation; (5) complications; (6) pain and other side effects; (7) patient acceptability; and (8) provider acceptability.
Primary Outcome
Length of D\&E procedure in minutes
Conditions Studied
Interventions
- DEVICE Dilapan-S
- DEVICE Laminaria
Study Locations (1)
New York
- Planned Parenthood of New York City - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-02 |
| Phase | NA |
What the finished NCT02033083 record still lists
NCT02033083 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Second Trimester Abortion appearing as the primary indexed condition, and to 2 interventions - of which Dilapan-S is the first listed.
NCT02033083 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02033083 about?
NCT02033083 is a clinical study titled "Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation". Primary objective: To study the difference in dilation and evacuation (D\&E) procedure time following overnight cervical preparation with laminaria or Dilapan-S™. The investigators hypothesize procedure time will be less with Dilapan-S™. Secondary objectives: To compare the use of laminaria and Dil...
What is the current status of trial NCT02033083?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2013-12. Estimated completion is 2016-02.
What conditions does trial NCT02033083 study?
This clinical trial studies the following conditions: Second Trimester Abortion.
What interventions are being tested in trial NCT02033083?
The interventions under investigation include: Dilapan-S (DEVICE), Laminaria (DEVICE).
Who is sponsoring clinical trial NCT02033083?
This trial is sponsored by Planned Parenthood of Greater New York, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02033083 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Second Trimester Abortion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02033083's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia